3343 Stock Market News for "CCEP"

PRNEWS is Now Accepting Entries for the 2019 Top Places to Work in PR and Communications

NEW YORK, June 24, 2019 /PRNewswire-PRWeb/ — PRNEWS’ Top Places to Work Awards program is now accepting submissions and PR, marketing and communications organizations of all sizes, worldwide are eligible to enter. Past winners are encouraged to keep their reputation as a Top Place to Work and enter for a consecutive year. The deadline to submit is Friday, July 12 and the late dead... »

Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At Conference

Shares of thinly traded, nano-cap biotech Achieve Life Sciences Inc (NASDAQ: ACHV) traded sharply higher Friday morning before paring those gains. Achieve, which develops Cytisinicline – a plant-based alkaloid with a high binding affinity to nicotinic acetylcholine receptor – for smoking cessation, said an abstract containing data from the Phase 2b trial dubbed ORCA-1 has been accepted for pr... »

Renewable Nation Video “DIY Q&A” Connecting Experts, Homeowners Accepting Questions Through July 12th

WASHINGTON–(BUSINESS WIRE)–Renewable Nation, the 100% noncommercial app for consumers seeking information on residential solar and other home energy improvement projects, is extending to July 12th the deadline for its video-based “DIY Q&A” program connecting homeowners with the experts who have the answers to their questions. Renewable Nation is accepting questions from homeowners ... »

Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference

SEATTLE, Wash. and VANCOUVER, British Columbia, June 21, 2019 /PRNewswire/ — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced that an abstract featuring data from the Phase 2b ORCA-1 trial has been accepted for oral presentation at the SRNT-E Annual Conference, to be held in Oslo, September 12-14, 2019. Th... »

All Biofrontera Management Board members intend to fully accept the partial tender offer by Maruho Deutschland GmbH for their shares

The Management Board intends to tender all personally held Biofrontera AG shares to Maruho Deutschland GmbH The Management Board intends to help Maruho Deutschland GmbH to successfully complete its offer and underlines the importance of the strategic partnership Should Deutsche Balaton AG prevail at the Annual General Meeting, the success of Biofrontera AG is at risk Leverkusen, Germany, June 21, ... »

First Acceptance Corporation Announces Organizational Changes

First Acceptance Corp. Companies Mentioned: Primary Exchange: OTCQXUnder the Symbol: FACO Thursday, June 20, 2019 5:15 PM NASHVILLE, TN / ACCESSWIRE / June 20, 2019 / First Acceptance Corporation (the “Company”) announced today that effective October 1, 2019, Larry Willeford, the Company’s Chief Claims Officer, will be promoted to President and Chief Operating Officer and take on... »

U.S. FDA Accepts Supplemental Biologics License Application (sBLA) for ULTOMIRIS® (ravulizumab-cwvz) under Priority Review for the Treatment of Atypical Hemolytic Uremic Syndrome (aHUS)

BOSTON–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the company’s supplemental Biologics License Application (sBLA) for ULTOMIRIS® (ravulizumab-cwvz), the company’s long-acting C5 complement inhibitor, for the treatment of people with atypical hemolytic uremic syndrome (aHUS... »

Camurus Receives IND Acceptance From the FDA to Enter Phase 3 with CAM2029 for Treatment of Acromegaly

LUND, Sweden, June 20, 2019 /PRNewswire/ — Camurus (NASDAQ STO: CAMX), a commercial stage biopharmaceutical company specializing in long-acting medicines for severe and chronic disorders, announced today the acceptance by the US Food and Drug Administration (FDA) of an Investigational New Drug (IND) application to initiate a Phase 3 study with CAM2029 once-monthly octreotide subcutaneou... »

FDA Accepts for Filing the Humanitarian Device Exemption Application For EMulate Therapeutics™ Hælo™ Pediatric System

SEATTLE, June 18, 2019 /PRNewswire-PRWeb/ — EMulate Therapeutics, Inc., a clinical-stage therapeutic device company developing non-invasive treatments for cancers and other serious diseases, announced it has received notice that the US Food and Drug Administration (FDA) accepted for filing the EMulate Therapeutics application for Humanitarian Device Exemption (HDE) for the Hælo Pediatric sys... »

FDA Accepts for Filing the Humanitarian Device Exemption Application For EMulate Therapeutics™ Hælo™ Pediatric System

SEATTLE, June 18, 2019 /PRNewswire-PRWeb/ — EMulate Therapeutics, Inc., a clinical-stage therapeutic device company developing non-invasive treatments for cancers and other serious diseases, announced it has received notice that the US Food and Drug Administration (FDA) accepted for filing the EMulate Therapeutics application for Humanitarian Device Exemption (HDE) for the Hælo Pediatric sys... »

Bellarmine Accepts ASUN Invitation; Knights Will Rise to NCAA Division I in 2020

LOUISVILLE, Ky.–(BUSINESS WIRE)–Bellarmine University’s president, Dr. Susan M. Donovan, announced today that she has accepted an invitation for the university to join the ASUN Conference. The move will elevate the university’s athletic programs to NCAA Division I status beginning next summer. Bellarmine will be the only private DI university in Kentucky, and one of the few Division I ... »

New Ohio Digital Learning School Now Open and Accepting Enrollments

TOLEDO, Ohio–(BUSINESS WIRE)–The Ohio Digital Learning School (ODLS), a tuition-free online public charter school, authorized by the Ohio Council of Community Schools (OCCS), welcomes families with students in grades 9-12 aged 16-21 who reside in Ohio to enroll for the 2019-20 academic year. Through its engaging web-based platform, live online learning sessions, and support from experi... »

California’s Solar on Multifamily Affordable Housing (SOMAH) Program to Begin Accepting Applications

SAN DIEGO–(BUSINESS WIRE)–California’s new Solar on Multifamily Affordable Housing (SOMAH) program, the nation’s largest investment in low-income residential solar for tenants, will begin accepting applications on July 1, 2019. The SOMAH program provides property owners with financial incentives for installing solar photovoltaic energy systems on housing serving low-income and disadvan... »

Consumers ‘won’t accept it’ — ex-retailer says stores can forget price hikes to offset tariffs

Major retailers are making changes behind-the-scenes to offset any costs from the Chinese tariffs, says ex-department store executive Jan Kniffen. »

Voltaic Minerals Corp. Receives Conditional TSXV Acceptance for Binding Letter of Intent with 1146915 B.C. Ltd.

Voltaic Minerals Corp. Receives Conditional TSXV Acceptance for Binding Letter of Intent with 1146915 B.C. Ltd.

Not for Distribution to U.S. News Wire Services or for Dissemination in the United States. VANCOUVER, BC / ACCESSWIRE / June 14, 2019 / Voltaic Minerals Corp. (TSX.V:VLT) (the “Corporation” or “Voltaic“) is pleased to announce that it has received TSX Venture Exchange conditional acceptance for the binding Letter of Intent (“LOI“) dated April 17, 2019 with 11469... »